Durvalumab

Modify Date: 2025-08-25 20:57:55

Durvalumab Structure
Durvalumab structure
Common Name Durvalumab
CAS Number 1428935-60-7 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Durvalumab


Durvalumab (MEDI 4736) is an humanized anti-PD-L1 monoclonal antibody. Durvalumab blocks the interaction of PD-L1 with PD-1 and CD80[1].

 Names

Name Durvalumab

 Durvalumab Biological Activity

Description Durvalumab (MEDI 4736) is an humanized anti-PD-L1 monoclonal antibody. Durvalumab blocks the interaction of PD-L1 with PD-1 and CD80[1].
Related Catalog
References

[1]. Faiena I, et al. Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma. Drug Des Devel Ther. 2018 Jan 23;12:209-215.

 Chemical & Physical Properties

Storage condition 2-8℃
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.